21719 results for «»
21719 results
#1 - Natural history and prognosis of tricuspid valve disease
23 Sep 2021
PCR Webinar with M. Metra, F. Praz, M. Sitges, E. Donal, R. Hahn, D. Muraru and Y. Topilsky
Jérôme Ferrara
Marseille, France
PCR Tokyo Valves 2021: Dive into the Scientific Programme!
Ahmet Zengin
Istanbul, Türkiye
Anthony Camuglia
Brisbane, Australia
Suguru Hirose
Tochigi, Japan
Tsuyoshi Kaneko
St. Louis, United States of America
Antiplatelet therapy in patients with conservatively managed spontaneous coronary artery dissection from the multicentre DISCO registry
20 Aug 2021
The aims of this study were to assess the use of antiplatelet drugs in medically treated spontaneous coronary artery dissection (SCAD) patients and to investigate the relationship between single (SAPT) and dual (DAPT) antiplatelet regimens and 1-year patient outcomes.
Reviewer
Reviewer
Xiangbin Pan
Beijing, China
Stent expansion indexes to predict clinical outcomes: an IVUS substudy from ADAPT-DES
23 Aug 2021
The purpose of the present investigation was to revisit all stent expansion indexes to identify the best predictor of 2-year percutaneous coronary intervention (PCI) lesion-specific outcome measures (i.e. clinically-driven target lesion revascularization [TLR] or definite stent thrombosis) using the ADAPT-DES IVUS substudy cohort.
Reviewer
PCR Tokyo Valves 2021 – What's on?
Challenging Left Main Cases
18 May 2021 – From EuroPCR 2021
Watch this session to learn how to treat a challenging LM case in a young patient, to question the need to treat residual LAD disease after PPCI for an inferior STEMI, to find out more about complex left main bifurcation PCI with OCT control, and to...
MASTER DAPT: dual antiplatelet therapy after coronary stenting in high bleeding risk patients - interview with Marco Valgimigli
28 Aug 2021
ESC Congress 2021: Discover the interview given by Marco Valgimigli to Luis G. Ortega-Paz for PCRonline about the MASTER-DAPT trial to assess whether one month of dual antiplatelet therapy preserves the net and major adverse cardiovascular events.
Author
Author
STOPDAPT-2 ACS: exploring the limits of short DAPT
31 Aug 2021
Hirotoshi Watanabe (Kyoto, Japan) presented the results of the STOPDAPT-2 ACS trial in a Hot Line session of the ESC Congress 2021. Dejan Milasinovic provides his analysis of this study.
Author
ENVISAGE-TAVI AF: edoxaban vs. vitamin K antagonists after TAVI in patients with atrial fibrillation
31 Aug 2021
Following the Hot Line session of the ESC Congress 2021 presented by George Dangas (New-York, USA), Daniele Giacoppo offers us a condensed version of this study.
Author
TOMAHAWK: immediate angiography after out-of-hospital cardiac arrest without ST-segment elevation
29 Aug 2021
Elad Asher analyses this study which compared the benefits of immediate coronary angiography with those of initial intensive care assessment with delayed angiography after out-of-hospital cardiac arrest. Hot Line session of the ESC Congress 2021.
Author
RIPCORD 2: does routine pressure wire assessment influence management strategy of coronary angiography for diagnosis of chest pain?
29 Aug 2021
Nicola Ryan presents a synthesis of this study which compares FFR-guided assessment of patients with chest pain with angiographic guidance alone, and which was presented by Nicholas Curzen (Southampton, USA) during the ESC Congress 2021.
Author
RIPCORD 2: influence of routine pressure wire assessment on management strategy of coronary angiography for diagnosis of chest pain - interview with Nick Curzen
29 Aug 2021
Panos Xaplanteris interviews Nick Curzen about this study on FFR-guided assessment of patients with chest pain when compared with angiographic guidance alone which was presented during ESC Congress 2021.
Author
Author
ACST-2 (Second asymptomatic carotid surgery trial): stenting vs. surgery for tight carotid stenosis
26 Aug 2021
Ali Nazmi Calik and Pascal Meier review this trial comparing CEA with CAS for patients with asymptomatic carotid stenosis, which was presented by Alison Halliday (Oxford, United Kingdom of Great Britain & Northern Ireland) during a Hot Line session of the ESC Congress 2021.
Author
Author
Amulet IDE: Amplatzer Amulet left atrial appendage occluder randomised controlled trial
31 Aug 2021
Luigi Biasco reports the best of Dj Lakkireddy (Overland Park, USA)'s presentation of the AMULET IDE trial at the Monday, August 30 Hot Line session of the ESC Congress 2021.
Author
